跳至主要内容
临床试验/NCT06476080
NCT06476080尚未招募不适用

Ultrasound Guided Serratus Anterior Versus Erector Spinae Block in Pain Alleviation in Acute Herpes Zoster: A Prospective Comparative Study

Minia University0 个研究点目标入组 120 人开始时间: 2024年7月5日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
120
主要终点
pain score

研究概览

简要总结

Acute herpes zoster pain is very severe . Conventional analgesics may be of no value. Regional blocks may play a role

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
30 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult population between 30 and 75 years old.
  • Unilateral painful thoracic herpetic eruption of less than one week duration.
  • VAS more than or equal 4, persistent pain in spite of proper antiviral and analgesic therapy, (800 mg oral acyclovir, 5 times per day, for one week), pregabalin 300 mg per day, acetaminophen 1000 mg per day, topical calamine lotion).

排除标准

  • Diabetic patients.
  • Painful herpetic eruptive vesicles more than one week.
  • Abdominal herpetic eruptions.
  • Non-compliant on anti-viral (bulbar palsy for example).
  • Co-malignancy or radiotherapy.
  • Steroid therapy > 5 mg prednisolone or its equivalent.
  • Infections or hematoma at site of injection.
  • Coagulopathy (chronic kidney or liver disease, clopidogrel use).

结局指标

主要结局

pain score

时间窗: immediate after injection, 1 week, 1, 3 months

Visual analogue scale from 0 to 10. 0= NO pain, 1-3=mild tolerable pain, 4-6= moderate pain, 7-10= severe untearable pain.

次要结局

  • Number of patients with pain recurrence(1 week, 1, and 3 months)
  • analgesic consumption(1 week, 1, and 3 months)
  • Incidence of treatment related adverse events(immediately after injection)

研究者

发起方
Minia University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mina Maher

Ass professor anesthesia and pain

Minia University

相似试验